Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiyuki Soeda

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Nature Communications|December 17, 2015
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groupsYoshiyuki Soeda, Misato Yoshikawa, Osborne F X Almeida, et al.
Movement Disorders Clinical Practice|April 12, 2024
Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ MutationHiroyuki Morino, Takashi Kurashige, Yukiko Matsuda, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Nature Communications|December 17, 2015
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groupsYoshiyuki Soeda, Misato Yoshikawa, Osborne F X Almeida, et al.
Movement Disorders Clinical Practice|April 12, 2024
Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ MutationHiroyuki Morino, Takashi Kurashige, Yukiko Matsuda, et al.
Pageof 3